MilliporeSigma Breaks Ground on its First U.S. Lateral Flow Membrane Production Facility
MilliporeSigma broke ground at its Sheboygan, Wisconsin site, for the company’s first lateral flow membrane production facility in the U.S.
Read MorePosted by Andy Lundin | Jul 18, 2022 | Company News, Rapid Assays |
MilliporeSigma broke ground at its Sheboygan, Wisconsin site, for the company’s first lateral flow membrane production facility in the U.S.
Read MorePosted by Andy Lundin | Jul 18, 2022 | Company News |
Northwest Pathology announced that with its earlier acquisition of Avero Diagnostics in 2021, the company adopted the Avero Diagnostics name.
Read MorePosted by Andy Lundin | Jul 15, 2022 | Covid 19 |
Investigators found that patients with severe COVID had clots in small venous and arterial blood vessels in skin that appears normal.
Read MorePosted by Andy Lundin | Jul 15, 2022 | Covid 19, Rapid Assays |
A new study identified a new, practical strategy for COVID surveillance on the part of larger groups of people through regular rapid antigen.
Read MorePosted by Andy Lundin | Jul 15, 2022 | Emerging & Zoonotic Diseases |
Amid rising concerns about a lack of testing to stop the spread of the monkeypox virus, Neelyx Labs, is now processing monkeypox PCR tests.
Read More